Active ingredientPiribedilCat. No. P-P135-001CAS 3605-01-4Family · Pharmaceutical analytical standards
Piribedil
A piperazine-type agonist of dopamine D2 and D3 receptors, first marketed in 1969 and used, in a prolonged-release oral form, for the motor symptoms of Parkinson's disease. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was one of the first dopamine agonists ever marketed and, unlike bromocriptine, it is not derived from ergot; it also blocks alpha-2 adrenergic receptors.
Go to the active ingredient →Active ingredientPiribedilCat. No. P-P135-001CAS 3605-01-4
Isotopically labelledPiribedil-d8Cat. No. P-P135-002CAS 1398044-45-5
Impurity1,2-Bis(chloromethoxy)benzeneCat. No. P-P135-003CAS 1580471-72-2
ImpurityPiribedil Impurity 1Cat. No. P-P135-004CAS 50602-51-2
ImpurityDesmethylene PiribedilCat. No. P-P135-005CAS 50602-50-1
ImpurityDibenzo(d,i)(1,3,6,8)tetraoxecineCat. No. P-P135-006CAS 263-29-6
ImpurityPiperonyl chlorideCat. No. P-P135-007CAS 20850-43-5
ImpurityPiribedil Impurity 2Cat. No. P-P135-008CAS 42123-22-8
ImpurityPiribedil Impurity 3Cat. No. P-P135-009CAS 132129-99-8
ImpurityPiribedil N-OxideCat. No. P-P135-010CAS 53954-71-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.